Acrux Limited (ASX:ACR)
0.0230
0.00 (0.00%)
Apr 29, 2025, 3:33 PM AEST
Acrux Revenue
Acrux had revenue of 120.00K AUD in the half year ending December 31, 2024, a decrease of -91.56%. This brings the company's revenue in the last twelve months to 802.00K, down -92.98% year-over-year. In the fiscal year ending June 30, 2024, Acrux had annual revenue of 5.09M, down -39.60%.
Revenue (ttm)
802.00K
Revenue Growth
-92.98%
P/S Ratio
11.68
Revenue / Employee
18.65K
Employees
43
Market Cap
9.37M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 5.09M | -3.34M | -39.60% |
Jun 30, 2023 | 8.43M | 6.71M | 390.34% |
Jun 30, 2022 | 1.72M | 382.00K | 28.57% |
Jun 30, 2021 | 1.34M | 84.00K | 6.70% |
Jun 30, 2020 | 1.25M | 622.00K | 98.57% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |